Evidence map›Paper›PMID 41413063›Full record

ArticleNPJ biofilms and microbiomes2025

Beyond colonization: Candida albicans exhibits substantial pathogenic potential in cystic fibrosis environments.

Natasa Radakovic, Nikola Plackic, Jelena Djuris, Joachim Morschhäuser, Aleksandar Sovtic, Mihail Basa, Predrag Minic, Fabio Zobi, Aleksandar Pavic

Abstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natasa RadakovicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Nikola PlackicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Jelena DjurisUniversity of Belgrade - Faculty of Pharmacy, Belgrade, Serbia.
Joachim MorschhäuserInstitute of Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Aleksandar SovticMother and Child Health Institute of Serbia "Dr. Vukan Čupić", Belgrade, Serbia.
Mihail BasaMother and Child Health Institute of Serbia "Dr. Vukan Čupić", Belgrade, Serbia.
Predrag MinicMother and Child Health Institute of Serbia "Dr. Vukan Čupić", Belgrade, Serbia.
Fabio ZobiDepartment of Chemistry, Fribourg University, Fribourg, Switzerland.
Aleksandar PavicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia. aleksandar.pavic@imgge.bg.ac.rs.

Funding

Ministry of Science, Technological Development, and Innovation of the Republic of Serbia 451-03-47/2023-14/200042 and 451-03-66/2024-03/200042
6 · The paper itself

Abstract

Cystic fibrosis (CF) sputum represents a highly permissive niche for microbial colonization, yet the contribution of Candida albicans to disease progression remains insufficiently investigated despite its frequent detection in CF airways. We hypothesized that the heterogeneous nature of CF lung, reflected through the emergence of oxygen-depleted niches during disease progression, modulates C. albicans pathogenicity and antifungal susceptibility. Using complementary in vitro and in vivo approaches, we show that clinical CF isolates of C. albicans are virulent in CF-mimicking environments. Synthetic CF medium (SCFM2) supported robust filamentation, with oxygen-nutrient interplay critically shaping fungal growth and drug response. In a novel CF infection model using zebrafish morphants, we observed heightened susceptibility to C. albicans compared to wild-type embryos. Reporter strains showed elevated ECE1 expression, indicating increased candidalysin production and virulence in vivo. Our study provides compelling evidence that CF isolates of C. albicans have pathogenic potential, warranting consideration in future therapeutic strategies.

Indexed as

Candida albicansCandidiasisCystic FibrosisAnimalsAntifungal AgentsDisease Models, AnimalFungal ProteinsHumansLungMicrobial Sensitivity TestsOxygenSputumVirulenceZebrafishAntifungal AgentsECE1 protein, Candida albicansFungal ProteinsOxygen

Identifiers

PMID41413063
PMCPMC12848021

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.